title: Future of oral iron chelator deferiprone. (L1) ICOC committee.
authors.forename: G J
authors.initials: GJ
authors.lastname: Kontoghiorghes
authors.forename: M B
authors.initials: MB
authors.lastname: Agarwal
authors.forename: P
authors.initials: P
authors.lastname: Tondury
authors.forename: M J
authors.initials: MJ
authors.lastname: Kersten
authors.forename: M
authors.initials: M
authors.lastname: Jaeger
authors.forename: G
authors.initials: G
authors.lastname: Vreugdenhil
authors.forename: A
authors.initials: A
authors.lastname: Vania
authors.forename: Y E
authors.initials: YE
authors.lastname: Rahman
mesh_terms: D000818:Animals; D015913:Chelation Therapy / Q000009:adverse effects*; D000077543:Deferiprone; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D011728:Pyridones / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone